Fuso Pharmaceutical Industries,Ltd. Sustainability Profile
Fuso Pharmaceutical Industries, Ltd., commonly referred to as Fuso Pharma, is a prominent player in the pharmaceutical industry, headquartered in Japan. Established in 1950, the company has made significant strides in developing innovative healthcare solutions, primarily focusing on prescription pharmaceuticals and over-the-counter products. With a strong operational presence in Asia and beyond, Fuso Pharma is renowned for its commitment to quality and research-driven approaches. The company’s core offerings include a diverse range of therapeutic agents, particularly in the fields of oncology and infectious diseases, distinguished by their efficacy and safety profiles. Fuso Pharmaceutical Industries has achieved notable recognition within the market, positioning itself as a trusted name in healthcare. Its dedication to advancing medical science and improving patient outcomes underscores its pivotal role in the global pharmaceutical landscape.
DitchCarbon Score
How does Fuso Pharmaceutical Industries,Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fuso Pharmaceutical Industries,Ltd.'s score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fuso Pharmaceutical Industries,Ltd.'s reported carbon emissions
Fuso Pharmaceutical Industries, Ltd., headquartered in Japan, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As of now, Fuso Pharmaceutical Industries, Ltd. does not inherit emissions data from any parent or related organizations, nor does it have any cascading targets from initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and climate commitments. However, without specific data or targets, it is unclear how Fuso Pharmaceutical Industries, Ltd. aligns with these industry trends.
How Carbon Intensive is Fuso Pharmaceutical Industries,Ltd.'s Industry?
How Carbon Intensive is Fuso Pharmaceutical Industries,Ltd.'s Location?
Fuso Pharmaceutical Industries,Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fuso Pharmaceutical Industries,Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Outset Medical, Inc.
Quanta Dialysis Technologies Limited
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.